← Back to Search

Behavioural Intervention

High-Intensity Interval Training (HIIT) After Breast Cancer Chemotherapy

N/A

Recruiting

Led By Demetra Christou, PhD

Research Sponsored by University of Florida

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Aged 18 to 85 years

Female patients based on biological sex

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, following a 12-week intervention period, following a 12-week observation period

Awards & highlights

Study Summary

This trial will examine if a new type of exercise can help reduce CVD risk in breast cancer survivors, who are more likely to get CVD due to chemotherapy.

Who is the study for?

This trial is for female breast cancer survivors, aged 18-85, who finished chemotherapy over 6 months ago but less than a year. They should not have severe lymphedema or cardiovascular diseases and mustn't be pregnant or involved in other studies that could affect results.Check my eligibility

What is being tested?

The study tests high-intensity interval training against moderate-intensity continuous training for improving heart health after breast cancer treatment. It includes a 12-week exercise program followed by a 12-week observation period to see which method is more effective.See study design

What are the potential side effects?

While the document doesn't list specific side effects, exercise programs can sometimes lead to muscle soreness, fatigue, and in rare cases with intense activity, there's a risk of injury or exacerbating underlying health conditions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 85 years old.

Select...

I am biologically female.

Select...

I have been diagnosed with early-stage (I-III) breast cancer that has not spread.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, following a 12-week intervention period, following a 12-week observation period

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, following a 12-week intervention period, following a 12-week observation period

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, following a 12-week intervention period, following a 12-week observation period for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in brachial FMD

Change in cardiac function (global longitudinal strain)

Number of participants who experience adverse events as defined by most recent CTCAE throughout the exercise intervention

+3 more

Trial Design

3Treatment groups

Experimental Treatment

Group I: Usual Care (UC)Experimental Treatment2 Interventions

Research participants will continue their habitual physical activity for the duration of the study. Once they complete the study, they will have the opportunity to perform supervised HIIT or MICT at home for 3 days/week for 12 weeks (research participants can choose either type of exercise).

Group II: Moderate Intensity Continuous Training (MICT)Experimental Treatment2 Interventions

Supervised home-based moderate-intensity continuous training will be performed on an all-extremity stationary cycle 3 days/week for 12 weeks.

Group III: High Intensity Interval Training (HIIT)Experimental Treatment2 Interventions

Supervised home-based high-intensity interval training will be performed on an all-extremity stationary cycle 3 days/week for 12 weeks.

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of FloridaLead Sponsor

1,341 Previous Clinical Trials

715,488 Total Patients Enrolled

13 Trials studying Breast Cancer

433 Patients Enrolled for Breast Cancer

National Institute on Aging (NIA)NIH

1,675 Previous Clinical Trials

28,020,727 Total Patients Enrolled

13 Trials studying Breast Cancer

40,291 Patients Enrolled for Breast Cancer

Demetra Christou, PhDPrincipal InvestigatorUniversity of Florida

7 Previous Clinical Trials

291 Total Patients Enrolled

1 Trials studying Breast Cancer

68 Patients Enrolled for Breast Cancer

Media Library

High-intensity Interval Training (HIIT) (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05913713 — N/A

Breast Cancer Research Study Groups: Moderate Intensity Continuous Training (MICT), Usual Care (UC), High Intensity Interval Training (HIIT)

Breast Cancer Clinical Trial 2023: High-intensity Interval Training (HIIT) Highlights & Side Effects. Trial Name: NCT05913713 — N/A

High-intensity Interval Training (HIIT) (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05913713 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Can I have the opportunity to participate in this clinical experiment?

"The parameters for this medical trial stipulate that participants must have a diagnosis of breast cancer and be aged between 18-85 years. In total, 158 patients are expected to enrol in the study."

Answered by AI

Does the age restriction for this experiment exclude people under fifty?

"This study is accepting volunteers aged 18 and above, but no older than 85."

Answered by AI

Are any more participants being accepted into this clinical trial at present?

"Unfortunately, this particular study is no longer accepting patients. It was posted on August 1st 2023 and the latest amendments to its protocol were made on June 13th 2023; however, 2649 other medical trials are still recruiting participants at this time."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

HIIT Following Breast Cancer Chemotherapy

2024. "HIIT Following Breast Cancer Chemotherapy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05913713.